【摘要】 目的:观察氨溴索联合干扰素γ雾化吸入法治疗慢性支气管炎急性发作的临床效果。方法:选取我院自2006年1月至2009年12月收治的慢性支气管炎急性发作的患者126例随机分为观察组(联合治疗组)和对照组(氨溴索治疗组)各63例,观察比较两组的治疗效果。结果:观察组痊愈32例,显效21例,有效10例,总有效率为84.1%;对照组痊愈11例,显效19例,有效26例,总有效率为47.7%。两组比较差异显著(P<0.01),具有统计学意义。两组在咳嗽咯痰、脓痰、呼吸困难等症状缓解时间比较上均有显著差异(P<0.05),具有统计学意义。结论:氨溴索联合干扰素γ雾化吸入法治疗慢性支气管炎急性发作效果理想,值得临床推广使用。更多还原

【Abstract】 Objective: To observe the clinical effect of ambroxol in combination with interferon γ inhalation on acute exacerbation of chronic bronchitis.Method: In our hospital from January 2006 to December 2009 admitted to acute exacerbation of chronic bronchitis,126 patients were randomly divided into two groups(combined treatment group) and control group(ambroxol treatment group),each with 63 cases,curative effects were observed and compared.Result: 32 cases were cured,markedly effective in 21 cases,effective in 10 cases,total effective rate was 84.1%;control group healed in 11 cases,19 cases were markedly,effective in 26 cases,total effective rate was 47.7%.There’s significant difference between the two groups(P <0.01),There’s statistical significance.Cough and sputum in both groups,dyspnea relief time comparison showed significant difference(P <0.05),with statistical significance.Conclusion: It’s effctive to treat acute exacerbation of chronic bronchitis with ambroxol in combination with interferon γ inhalation,the results are satisfactory,is worthy of clinical use.更多还原